UMIN000051442Enrolling by invitation
The renal benefits of Tirzepatide for type 2 diabetes subjects with chronic kidney disease: prospective observational study
Kushiro Red Cross HospitalUniversity Hospital Medical Information Network
VerifiedUniversity Hospital Medical Information Network
Study focus
- Disease/Condition
- Type 2 diabetes
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Kushiro Red Cross Hospital
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Jun 05, 2023
- End date
- N/A
ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus with multiple complications
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000051442
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000051442 through Pure Global AI's free database. This phase not specified trial is sponsored by Kushiro Red Cross Hospital and is currently Enrolling by invitation. The study focuses on Type 2 diabetes.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.